DNA microarray Cytochrome P450

Product Overview
This pharmacogenomics test chip is designed for clinical diagnostics. It enables comprehensive detection of genetic variants in the CYP2D6 and CYP2C19 genes, including point variants, gene deletions and duplications.

Catalog Number
GC-QCY-0003

Certification
FDA

Application
Intended for clinical diagnostic use to analyze genetic variations in cytochrome P450 enzymes (CYP2D6 and CYP2C19) to support pharmacogenomic assessment.

Test Items

• CYP2D6
• CYP2C19

Features

• Detects up to 33 CYP2D6 alleles and 3 CYP2C19 alleles
• Detects deletions and duplications in target genes
• Polymerase-carried protective function minimizes sample cross-contamination

Notes
For in vitro diagnostic use.

Technical specifications

• Product Name: Cytochrome P450 Test Chip
• Catalog No.: GC-QCY-0003
• Intended Use: Clinical diagnostic pharmacogenomics testing
• Target Genes: CYP2D6, CYP2C19
• Alleles Detected: Up to 33 CYP2D6 alleles; 3 CYP2C19 alleles
• Detectable Variations: Point variants, deletions, duplications
• Contamination Protection: Polymerase-carried protective function to prevent sample cross-contamination
• Certification: FDA
• For In Vitro Diagnostic Use